Increase in Total Plasma Homocysteine Concentration After Cardiac Transplantation

Mayo Clinic Proceedings

Volumn 70, Issue 2, 1995, Pages 125-131

  Berger, Peter B ^a   Jones, James D ^a   Olson, Lyle J ^a   Edwards, Brooks S ^a   Frantz, Robert P ^a   Rodeheffer, Richard J ^a   Kottke, Bruce A ^a,b   Daly, Richard C ^a   McGregor, Christopher G A ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b Watson Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; COTRIMOXAZOLE; CYANOCOBALAMIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOLIC ACID; HOMOCYSTEINE; LYMPHOCYTE ANTIBODY; OKT 3; PENTAMIDINE ISETHIONATE; PREDNISONE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DRUG HYPERSENSITIVITY; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HEART TRANSPLANTATION; HOMOCYSTINURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; VITAMIN BLOOD LEVEL;

EID: 0028850883     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/70.2.125     Document Type: Article

References (41)

1. Homocysteine theory of arteriosclerosis
2. Hyperhomocyst(e)inemia: a common and easily reversible risk factor for occlusive atherosclerosis
3. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
4. Heart transplantation: the South African experience
5. Heart transplantation for end-stage ischemic heart disease: the Stanford experience
6. Homocysteine and other thiols in plasma and urine: automated determination and sample stability
7. Radioassay of serum folate
8. 12 in blood: a simple method
9. Identification and quantitation of urinary dicarboxylic acids as their dicyclohexyl esters in disease states by gas chromatography mass spectrometry
10. Serial quantitative coronary angiography in the assessment of coronary disease in the transplanted heart
11. Intracoronary ultrasound imaging in heart transplant recipients: the Stanford experience
12. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of “angiographically silent” intimal thickening
13. Hypercholesterolemia in long-term survivors of heart transplantation; an early marker of accelerated coronary artery disease
14. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients
15. Are early and late cardiac allograft arteriopathy different entities? [abstract]
16. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients
17. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia
18. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
19. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy
20. Hyperhomocysteinemia: an independent risk factor for vascular disease
21. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease
22. Homocystine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis
23. Disorders of transsulfuration
24. 12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency
25. Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry
26. Homocysteinemia due to folate deficiency
27. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide
28. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism
29. Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis
30. Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease
31. Plasma protein-bound homocyst(c)ine in patients requiring chronic haemodialysis [letterl
32. Increased plasma homocysteine concentration in patients with chronic renal failure
33. Folic acid—an innocuous means to reduce plasma homocysteine
34. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
35. Observations on the incidence and cause of macrocytosis in patients on azathioprine dierapy following renal transplantation
36. Diminished serum folic acid levels in renal transplant recipients
37. Erythroid toxicity of azathioprine: macrocytosis and selective marrow hypoplasia
38. Macrocystosis and pure RBC anemia caused by azathioprine
39. Development of macrocytosis during azathioprine therapy after renal transplantation: a correlation of renal function with MCV
40. 12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone
41. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism